INTECH Investment Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-27,027
Closed -$19K – 2219
2026
Q1
$19K Sell
27,027
-17,334
-39% -$16.2K ﹤0.01% 2068
2025
Q4
$68.8K Sell
44,361
-3,541
-7% -$5.66K ﹤0.01% 2229
2025
Q3
$75.7K Sell
47,902
-13,481
-22% -$23.4K ﹤0.01% 2319
2025
Q2
$134K Buy
61,383
+965
+2% +$2.34K ﹤0.01% 2217
2025
Q1
$165K Buy
60,418
+28,206
+88% +$111K ﹤0.01% 2163
2024
Q4
$134K Buy
32,212
+19,098
+146% +$72.2K ﹤0.01% 2144
2024
Q3
$51K Buy
+13,114
New +$55.3K ﹤0.01% 1981

Other funds holding MXCT

INTECH Investment Management's MXCT Position: Q2 2026 in Review

INTECH Investment Management sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 27,027 shares — an estimated $19K sold.

INTECH Investment Management first reported a position in MXCT in Q3 2024 and held it in 7 quarters. The position peaked at $165K in Q1 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • INTECH Investment Management reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 27,027 MaxCyte shares in Q2 2026, an estimated $19K.
  • INTECH Investment Management first reported a position in MaxCyte in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's MaxCyte position peaked at $165K in Q1 2025.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.